STOCK TITAN

CELL MEDX CORP - $CMXC STOCK NEWS

Welcome to our dedicated page for CELL MEDX news (Ticker: $CMXC), a resource for investors and traders seeking the latest updates and insights on CELL MEDX stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CELL MEDX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CELL MEDX's position in the market.

Rhea-AI Summary
Cell MedX Corp. announces the closing of a non-brokered private placement offering, raising $75,000 by issuing 2,500,000 units at $0.03 per unit. Each unit includes a common stock share and a share purchase warrant. The offering targeted non-U.S. and U.S. persons, with a director of the company participating in the acquisition of 1,000,000 units.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
-
Rhea-AI Summary
Cell MedX Corp. (CMXC) announces the resignation of Brad Hargreaves from the Board of Directors, with no disagreement cited. The company expresses gratitude for his contributions and wishes him success in future endeavors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
management
-
Rhea-AI Summary
Cell MedX Corp. (CMXC) appoints Dr. George Adams as Chairman of the Board, bringing extensive experience in the biotech industry. Dr. Adams will lead the company through product enhancement and clinical trial implementations for the eBalance® technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
management
Rhea-AI Summary
Cell MedX Corp. (OTC Pink: CMXC) announces changes in executive leadership and debt settlement agreements resulting in a change in control of the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
330.77%
Tags
management
-
Rhea-AI Summary
Cell MedX Corp. (CMXC) has had the Cease Trade Order revoked by the British Columbia Securities Commission after filing its audited financial statements and related management's discussion and analysis, bringing the company up to date with its continuous disclosure obligations under Canadian securities laws.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
200%
Tags
none
-
Rhea-AI Summary
Cell MedX Corp. (OTC Pink: CMXC) appoints new members to its Audit Committee and announces the resignation of its Chief Operating Officer. The new appointees are Mr. Dwayne Yaretz, Mr. George Adams, and Mr. Joao (John) da Costa. Mr. da Costa will continue to serve as a director and audit committee member. The company also confirms the independence and financial literacy of the new committee members.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
CELL MEDX CORP

OTC:CMXC

CMXC Rankings

CMXC Stock Data

8.84M
59.94M
79.66%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Carson City

About CMXC

espa.ca is operated by avyonce cosmedics inc. our espa.ca website features a range of spa equipment, spa furniture and spa products. at avyonce cosmedics inc. we can help develop your spa from start up or work with you to upgrade your existing business. espa.ca offers the brands you can trust. combining performance, pleasure, safety and creativity, the team provides the highest quality equipment and products to ensure your clients will have an unforgettable spa experience.